FemPulse Corporation
PrivateLast Round
Series C
Mar 31, 2023
Company Overview
FemPulse Corporation is a bioelectronic medicine company developing a novel wearable platform for the personalized treatment of medical conditions in women, specifically overactive bladder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FemPulse Corporation Comparables
Compare FemPulse Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avation Medical | 81% | |
| Neuspera Medical | 80% | |
| Stimuli Technology | 78% | |
FemPulse Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 31, 2023 | ||||
| Series B | Apr 2, 2020 | ||||
| Early Funding | Dec 5, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2023
Raised Series C round
FemPulse Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FemPulse Corporation's valuation, stock price, and market status.